This analysis discusses Artera's pivot from a standard SaaS model to an 'AI Services' framework, where dedicated Agentic AI squads co-develop bespoke solutions for healthcare providers.
A weekly summary of Artera's strategic focus on deploying voice AI within clinical workflows, emphasizing measurable ROI and integration depth to strengthen its position in the healthcare communication market.
Atlantic Health has deployed Artera's AI agents to manage colonoscopy patient outreach, resulting in measurable improvements in appointment confirmation and patient engagement within the first 30 days.
Artera has partnered with Signify Research to release a new report providing a framework for healthcare leaders to evaluate AI voice solutions. This initiative positions Artera as a thought leader in the patient communication and healthtech space.
Artera commissioned an independent study by Signify Research to provide a framework for healthcare providers evaluating AI voice solutions. This positions Artera as a thought leader in the patient communication space and helps guide potential customers toward their specific technology.
Artera and Photocure have launched a joint research initiative to evaluate AI-powered digital pathology tests for bladder cancer. This partnership expands Artera's clinical footprint by integrating its precision medicine technology with Photocure's bladder cancer registry.
Photocure and Artera have launched a joint research initiative to validate the ArteraAI Bladder Test using Photocure's blue light cystoscopy registry data. This partnership aims to enhance precision medicine in uro-oncology by leveraging multimodal AI to improve bladder cancer treatment decisions.
Artera's Harmony Federal Edition platform has achieved FedRAMP Class D Certification, a significant security milestone that allows the company to expand its patient communication services to federal healthcare agencies like the VA and DoD.
Tempus AI and Artera have integrated the ArteraAI Prostate Test into the Tempus platform, providing clinicians with advanced digital pathology tools to personalize treatment for patients with metastatic hormone-sensitive prostate cancer.
Artera announced that its 'Artera Harmony Federal Edition' platform has achieved FedRAMP Authority to Operate, enabling the company to expand its patient communication and engagement services within federal healthcare agencies.
Artera CEO and Co-Founder Guillaume de Zwirek discusses the evolution of technology, the stages of agentic AI utilization, and strategies for effective AI deployment in healthcare settings.
This industry report highlights Artera's unveiling of its new AI Services Model for specialty care and FQHCs, marking the company's expansion into bespoke, provider-partnered AI solutions.
Artera unveiled a new AI Services Model designed to provide bespoke, agentic AI solutions for specialty care providers, FQHCs, and health systems, aiming to close the gap between technology and clinical workflows.
Headlines surfaced and scored by PortcoMonitor. Get the full, ranked feed + a daily briefing →